0000950172-24-000233.txt : 20240425 0000950172-24-000233.hdr.sgml : 20240425 20240425103514 ACCESSION NUMBER: 0000950172-24-000233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240424 FILED AS OF DATE: 20240425 DATE AS OF CHANGE: 20240425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glickman Richard M CENTRAL INDEX KEY: 0001352637 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37410 FILM NUMBER: 24873615 MAIL ADDRESS: STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION STREET 2: 1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ESSA Pharma Inc. CENTRAL INDEX KEY: 0001633932 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 BUSINESS PHONE: (778) 331-0962 MAIL ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 4 1 form4.xml X0508 4 2024-04-24 0001633932 ESSA Pharma Inc. EPIX 0001352637 Glickman Richard M C/O ESSA PHARMA INC. 999 WEST BROADWAY, SUITE 720 VANCOUVER A1 V5Z 1K5 BRITISH COLUMBIA, CANADA true false Common Shares 2024-04-24 4 M 0 3750 4.9 A 43240 D Options 4.9 2024-04-24 4 M 0 3750 0 D 2022-03-21 2024-05-21 Common Shares 3750 0 D /s/ Richard Glickman 2024-04-25